Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
Mitra D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, Wilhelm H, Tarade N, Poschet G, Buettner M, Binenbaum I, Borgoni S, Vetter M, Kantelhardt EJ, Thomssen C, Chatziioannou A, Hell R, Kempa S, Müller-Decker K, Wiemann S.
Mitra D, et al. Among authors: muller decker k.
Int J Cancer. 2021 Apr 15;148(8):1993-2009. doi: 10.1002/ijc.33456. Epub 2021 Jan 9.
Int J Cancer. 2021.
PMID: 33368291